{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:15:37Z","timestamp":1773900937364,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["209779"],"award-info":[{"award-number":["209779"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003452","name":"Innovation and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.gastha.2025.100844","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T07:51:24Z","timestamp":1762588284000},"page":"100844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis B Surface Antigen Loss and Improved Clinical Outcomes in Asians With Chronic Hepatitis B Virus Infection"],"prefix":"10.1016","volume":"5","author":[{"given":"Wallis","family":"Lau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8994-2816","authenticated-orcid":false,"given":"Myriam","family":"Drysdale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Morais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Antunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loey","family":"Mak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina","family":"Camarinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienne Y.L.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"May","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Gielen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dickens","family":"Theodore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian C.K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iain A.","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastha.2025.100844_bib2","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41575-024-00967-4","article-title":"Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions","volume":"21","author":"Mak","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2025.100844_bib4","article-title":"Hepatitis B burden and population immunity in a high endemicity city - a geographically random household epidemiology study for evaluating achievability of elimination","volume":"151","author":"Wong","year":"2023","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.gastha.2025.100844_bib5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41575-019-0197-8","article-title":"Clinical utility of HBV surface antigen quantification in HBV e antigen-negative chronic HBV infection","volume":"16","author":"Liaw","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2025.100844_bib6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.21037\/atm.2016.09.11","article-title":"Diagnosis of hepatitis B","volume":"4","author":"Song","year":"2016","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.gastha.2025.100844_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.42","article-title":"T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance","volume":"6","author":"Ye","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.gastha.2025.100844_bib8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cgh.2020.05.041","article-title":"Association between seroclearance of hepatitis B surface antigen and long-term clinical outcomes of patients with chronic hepatitis B virus infection: systematic review and meta-analysis","volume":"19","author":"Anderson","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2025.100844_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S2468-1253(18)30308-X","article-title":"Spontaneous loss of surface antigen among adults living with chronic hepatitis B virus infection: a systematic review and pooled meta-analyses","volume":"4","author":"Zhou","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2025.100844_bib10","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1097\/HEP.0000000000000431","article-title":"Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: report from the 2022 AASLD-EASL HBV-HDV treatment endpoints conference","volume":"78","author":"Ghany","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.gastha.2025.100844_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2024.199507","article-title":"Achieving chronic hepatitis B functional cure: factors and potential mechanisms","volume":"351","author":"Zheng","year":"2025","journal-title":"Virus Res"},{"key":"10.1016\/j.gastha.2025.100844_bib12","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.gastha.2023.06.004","article-title":"Clinical consequences of hepatitis B surface antigen loss in chronic hepatitis B infection: a systematic literature review and meta-analysis","volume":"2","author":"Morais","year":"2023","journal-title":"Gastro Hep Adv"},{"key":"10.1016\/j.gastha.2025.100844_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jhep.2018.10.014","article-title":"HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues","volume":"70","author":"Yip","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastha.2025.100844_bib14","article-title":"Population-based clinical studies using routinely collected data in Hong Kong, China: a systematic review of trends and established local practices","volume":"8","author":"Wu","year":"2023","journal-title":"Cardiovasc Innov Appl"},{"key":"10.1016\/j.gastha.2025.100844_bib15","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/sim.4780091214","article-title":"Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study","volume":"9","author":"D\u2019Agostino","year":"1990","journal-title":"Stat Med"},{"key":"10.1016\/j.gastha.2025.100844_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/apt.16659","article-title":"Systematic review with meta-analysis: the impact of functional cure on clinical outcomes in patients with chronic hepatitis B","volume":"55","author":"Vittal","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastha.2025.100844_bib17","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3390\/v15040997","article-title":"Evidence for benefits of early treatment initiation for chronic hepatitis B","volume":"15","author":"Lim","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.gastha.2025.100844_bib18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2147\/HMER.S291976","article-title":"Current perspectives on nucleos(t)ide analogue therapy for the long-term treatment of hepatitis B virus","volume":"14","author":"Broquetas","year":"2022","journal-title":"Hepat Med"},{"key":"10.1016\/j.gastha.2025.100844_bib19","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1111\/jgh.16728","article-title":"Regression of liver fibrosis after HBsAg loss: a prospective matched case-control evaluation using transient elastography and serum enhanced liver fibrosis test","volume":"39","author":"Mak","year":"2024","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2025.100844_bib20","article-title":"Identifying liver cirrhosis in patients with chronic hepatitis B: an interpretable machine learning algorithm based on LSM","volume":"57","author":"Pu","year":"2025","journal-title":"Ann Med"},{"key":"10.1016\/j.gastha.2025.100844_bib21","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1002\/hep.31610","article-title":"Comparison of long-term clinical outcomes between spontaneous and therapy-induced HBsAg seroclearance","volume":"73","author":"Choi","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.gastha.2025.100844_bib22","first-page":"68","article-title":"Durability of hepatitis B surface antigen seroclearance in untreated and nucleos(t)ide analogue-treated patients","volume":"63","author":"Yip","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastha.2025.100844_bib24","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s40121-023-00795-0","article-title":"Real-world epidemiology, clinical and economic burden of chronic hepatitis B in Japan: a retrospective study using JMDC claims database","volume":"12","author":"Umemura","year":"2023","journal-title":"Infect Dis Ther"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572325002316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572325002316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:49:58Z","timestamp":1773888598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572325002316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2772572325002316"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2025.100844","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis B Surface Antigen Loss and Improved Clinical Outcomes in Asians With Chronic Hepatitis B Virus Infection","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2025.100844","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}],"article-number":"100844"}}